抗菌药诱导的内毒素释放作用论文(2)

　　内毒素的生物活性广泛而强烈,对机体造成严重的损害。由于不同的抗菌诱导内毒素释放的量不同,因此在抗菌药的研究设计中除了考虑到杀菌效力外,还应考虑到可能诱导内毒素释放的问题。对于败血症病人,由于菌血症也是一个致死因素,抗菌药仍然是必不可少的治疗手段,因此,在治疗中应采取合理的治疗方案以防止或减轻内毒素血症。

参考文献

[1] Rietschel ET, Brade L, Lindner B, et al.Biochemistry oflipopolysaccharides. In: Morrison DC, Ryan JL, Eds.Bacterial endotoxic lipopolysaccharides. Vol.I.[M]. BocaRaton(USA): CRC Press, 1992:3

[2] Lehmann V, Freudenberg MA, Galanos C. Lethal toxici-ty of lipopolysaccharide and tumor necrosis factor in nor-mal andD-galactosamine-treated mice.[J]. J Exp Med,1987, 165:657

[3] McGroarty E. Biophysical aspects and function of endo-toxin. In: Nowotny A, Spitzer JJ, Ziegler EJ. Eds. Cel-lular and molecular aspects of endotoxin reations. [M].San Diego: International Endotoxin Society, 1990: 85

[4] Shenep JL, Flynn PM, Barrett FF, et al. Serial quantita-tion of endotoxemia sepsis.[J]. J Infect Dis ,1988, 157(3): 565

[5] Mustafa MM, McCracken GH. Increased endotoxin andinterleukin-1βconcentrations in cerebrospinal fluid of in-fants with coliform meningitis and ventriculitis associatedwith intraventricular gentamicin therapy. [J]. J InfectDis, 1989, 160(5):891

[6] Jackson JJ, Kropp H.β-lactam antibiotic-induced releaseof free endotoxin: in vitro comparison of penicillin-bindingprotein (PBP)2 specific imipenem and PBP3-specific cef-tazidime. [J]. J Infect Dis, 1992, 165(6):1033

[7] Dofferhoff ASM, Buys J. The influence of antibiotic-in-duced filament formation on the release of endotoxin fromGram-negative bacteria. [J]. J Endotoxin Res, 1996, 3(3):187

[8] Jackson JJ, Kropp H. Differences in mode of action ofβ-lactam antibiotics influence morphology, LPS release andin vivo antibiotic efficacy. [J]. J Endotoxin Res, 1996, 3(3):201

[9] Shenep JL, Mogan A. Kinetics of endotoxin release duringantibiotic therapy for experimental Gram-negative bacteri-al sepsis. [J]. J Infect Dis, 1984, 150(3): 380

[10] McConnel JS, Cohen J. Release of endotoxin fromEs-cherichia coliby quinolones. [ J ]. J AntimicrobChemother, 1986, 18(6):765

[11] Healy DP, Verst-Brasch CL, Clendening CE, et al. In-fluence of drug class and dose size on antibiotic-influcedendotoxin/IL-6 release and impact on efficacy of anti-en-dotoxin antibody. [J]. J Endotoxin Res, 1996, 3(3):219

[12] Walterspiel JW, Kaplan SL, Mason EO Jr. Protective ef-fect of subinhibitory polymyxin B alone and in combina-tion with ampicillin for overwhelmingHaemophilus in-fluenzaetype B infection in the infant rat: Evidence forin vivo and in vitro release of free enditoxin after ampi-cillin treatment. [J]. Pediatr Res, 1986, 20(3):237

[13] Arditi M, Kabat W, Yogev R. Antibiotic-induced bacte-rial killing stimulates tumor necrosis factor-αrelease inwhole blood. [J]. J Infect Dis,1993, 167(1):240

[14] Arditi M, Zhou J, Huang SH. Antibiotic induced bacteri-al killing activates vascular endothelial cells and wholeblood cells. [J]. J Endotoxin Res, 1996, 3(3):179

[15] Healy DP, Verst-Brasch CL, Clendening CE, et al. Ki-netics of endotoxin and interleukin-6 following multipledoses of antibiotics for experimental Gram-negative bac-terial sepsis. [J]. J Endotoxin Res,1996, 3(2):93

[16] Shenep JJ, Barton RP, Mogan KA. Role of antibioticclass in the rate of liberation of endotoxin during therapyfor experimental Gram-negative bacterial sepsis. [J]. JInfect Dis, 1985, 151(6):1012

[17] Neely AN, Holder IA. A murine model with aspects ofclinical relevance for the study of antibiotic-induced en-dotoxin release in septic hosts. [J]. J Endotoxin Res,1996, 3(3):229

[18] Bucklin SE, Fujihara Y, Leeson MC, et al. Differentialantibiotic-induced release of endotoxin from Gram-nega-tive bacteria. [J]. Eur J Clin Microbiol Infect Dis,1994,13 (Suppl):43

[19] Friedland IR, Jafari H, Ehret S, et al. Comparison ofendotoxin release by different antimicrobial agents andthe effect on inflammation in experimentalEscherichiacolimeningitis. [J]. J Infect Dis,1993, 168(3):657

[20] Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, etal. Effects of different types and combinations of antimi-crobial agent on endotoxin release from Gram-negativebacteria: an in vitro and in vivo study. [J]. Scand J In-fect Dis,1991, 23(6):745

[21] Arditi M, Ables L, Yogev R. Cerebrospinal fluid endo-toxin levels in children withH.influenzaemeningitis be-fore and after administration of intravenous ceftriaxone.[J]. J Infect Dis,1989, 160(6):1005

[22] Hurley JC, Louis WJ, Tosolini FA, et al. Antibiotic-in-duced release of endotoxin in chronically bacteriuric pa-tients. [J]. Antimicrob Agents Chemother, 1991, 35(11):2388

[23] Neu HC. Relation of structural properties of beta-lactamantibiotics to antibacterial activity. [J]. Am J Med,1985, 79 (Suppl 2A) 2

[24] Jackson JJ, Kropp H. Reply: beta-lactam antibiotic-in-duced release of lipopolysaccharide. [J]. J Infect Dis,1993, 167(4):775

[25] Marra MN, Wilde GG, Griffith JE, et al. Bactericidal/permeability-increasing protein has endotoxin-neutraliz-ing activity. [J]. J Immunol,1990, 144(2):662

[26] Liang AH, Ohno N, Yadomae T. Inhibition of antibiotic-induced lysis and lipopolysaccharide release fromEs-cherichia coliO111:B4 by egg white lysozyme. [J]. JEndotoxin Res, 1997, 4(2):105

[27] Liang A, Ohno N, Yadomae T. Egg white lysozyme in-hibits ceftazidime-induced endotoxin release and filamen-tation ofEscherichia coliO111:B4. [J]. Drug Dev Res,1998,44:70

[28] Liang A, Sugawara N, Ohno N, et al. Effect ofO-anti-genic polysaccharide ofEscherichia colion endotoxin neu-tralizing activity of lysozyme. [J]. FEMS Immunol MedMicrob, 1998;21:79

   [2]